Jack E. Heron

431 total citations
12 papers, 262 citations indexed

About

Jack E. Heron is a scholar working on Infectious Diseases, Emergency Medicine and Epidemiology. According to data from OpenAlex, Jack E. Heron has authored 12 papers receiving a total of 262 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Infectious Diseases, 8 papers in Emergency Medicine and 3 papers in Epidemiology. Recurrent topics in Jack E. Heron's work include HIV/AIDS drug development and treatment (9 papers), HIV/AIDS Research and Interventions (8 papers) and HIV-related health complications and treatments (8 papers). Jack E. Heron is often cited by papers focused on HIV/AIDS drug development and treatment (9 papers), HIV/AIDS Research and Interventions (8 papers) and HIV-related health complications and treatments (8 papers). Jack E. Heron collaborates with scholars based in Australia, Zimbabwe and Switzerland. Jack E. Heron's co-authors include Annette Burgess, Jane Bleasel, Eszter Kalman, David M. Gracey, Corinne Isnard Bagnis, Catherine OʼConnor, Steven J. Chadban, Alexander Gilbert, Chiratidzo E. Ndhlovu and Tinei Shamu and has published in prestigious journals such as PLoS ONE, AIDS and BMC Medical Education.

In The Last Decade

Jack E. Heron

11 papers receiving 253 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jack E. Heron Australia 5 84 78 67 38 29 12 262
Laurie Fraticelli France 9 53 0.6× 58 0.7× 27 0.4× 20 0.5× 28 1.0× 34 399
Rebecca Wallihan United States 9 112 1.3× 39 0.5× 33 0.5× 27 0.7× 9 0.3× 22 328
Manal Bouhaimed Kuwait 9 127 1.5× 43 0.6× 15 0.2× 45 1.2× 26 0.9× 14 338
Paige McDonald United States 11 80 1.0× 52 0.7× 19 0.3× 108 2.8× 10 0.3× 31 343
Amir Maroof Khan India 10 57 0.7× 23 0.3× 21 0.3× 20 0.5× 20 0.7× 31 249
Mohamed Al-Moamary Saudi Arabia 11 153 1.8× 55 0.7× 12 0.2× 97 2.6× 11 0.4× 31 411
Dominick DeBlasio United States 10 77 0.9× 23 0.3× 17 0.3× 23 0.6× 62 2.1× 30 305
Nilton Yhuri Carreazo Peru 8 27 0.3× 32 0.4× 24 0.4× 34 0.9× 11 0.4× 32 328
Nigel Barr Australia 9 97 1.2× 28 0.4× 32 0.5× 105 2.8× 5 0.2× 30 363
Alison Riese United States 10 77 0.9× 9 0.1× 29 0.4× 44 1.2× 30 1.0× 24 306

Countries citing papers authored by Jack E. Heron

Since Specialization
Citations

This map shows the geographic impact of Jack E. Heron's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jack E. Heron with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jack E. Heron more than expected).

Fields of papers citing papers by Jack E. Heron

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jack E. Heron. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jack E. Heron. The network helps show where Jack E. Heron may publish in the future.

Co-authorship network of co-authors of Jack E. Heron

This figure shows the co-authorship network connecting the top 25 collaborators of Jack E. Heron. A scholar is included among the top collaborators of Jack E. Heron based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jack E. Heron. Jack E. Heron is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Heron, Jack E., Hamish McManus, Tobias Vickers, et al.. (2023). Renal impairment associated with tenofovir disoproxil fumarate for antiretroviral therapy and HIV pre-exposure prophylaxis: An observational cohort study. PLoS ONE. 18(2). e0280339–e0280339. 2 indexed citations
2.
Heron, Jack E., et al.. (2022). Predictors of renal impairment and proteinuria after commencement of antiretroviral therapy in a Zimbabwean HIV cohort. HIV Medicine. 23(9). 1002–1006. 1 indexed citations
3.
Heron, Jack E., et al.. (2021). Baseline renal function predicts mortality in adolescents commenced on HIV antiretroviral therapy. AIDS. 35(5). 843–845. 2 indexed citations
4.
McManus, Hamish, Tobias Vickers, Jack E. Heron, et al.. (2021). Renal impairment in a large-scale HIV preexposure prophylaxis implementation cohort. AIDS. 35(14). 2319–2326. 5 indexed citations
5.
Shamu, Tinei, et al.. (2021). Renal function and associated mortality risk in adults commencing HIV antiretroviral therapy in Zimbabwe. AIDS. 36(5). 631–636. 4 indexed citations
6.
Heron, Jack E., et al.. (2020). Renal proximal tubulopathy in an HIV-infected patient treated with tenofovir alafenamide and gentamicin: a case report. BMC Nephrology. 21(1). 339–339. 3 indexed citations
7.
Heron, Jack E., Corinne Isnard Bagnis, & David M. Gracey. (2020). Contemporary issues and new challenges in chronic kidney disease amongst people living with HIV. AIDS Research and Therapy. 17(1). 11–11. 48 indexed citations
8.
Gilbert, Alexander, et al.. (2020). Risk factors for development of acute kidney injury in hospitalised adults in Zimbabwe. PLoS ONE. 15(10). e0241229–e0241229. 7 indexed citations
9.
Heron, Jack E., et al.. (2020). Body mass index and noninfectious comorbidity in HIV‐positive patients commencing antiretroviral therapy in Zimbabwe. HIV Medicine. 21(10). 674–679. 2 indexed citations
10.
Heron, Jack E., et al.. (2020). Renal impairment: an unnecessary barrier to HIV prevention. Sexual Health. 17(3). 299–300.
11.
Heron, Jack E., et al.. (2019). The prevalence and risk of non-infectious comorbidities in HIV-infected and non-HIV infected men attending general practice in Australia. PLoS ONE. 14(10). e0223224–e0223224. 29 indexed citations
12.
Burgess, Annette, et al.. (2019). Medical students: what educational resources are they using?. BMC Medical Education. 19(1). 36–36. 159 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026